目的分析胃乐新联合兰索拉唑肠溶胶囊治疗消化性胃溃疡的效果。方法 89例消化性胃溃疡患者,将其随机分为对照组(43例)与观察组(46例)。对照组给予胃乐新治疗,观察组在对照组基础上加用兰索拉唑治疗。比较两组治疗效果。结果治疗前两组腹部隐痛、嗳气反酸、恶心呕吐、腹泻腹胀积分比较差异均无统计学意义(P>0.05);治疗后两组各症状积分均较治疗前明显下降,且观察组低于对照组,差异均具有统计学意义(P<0.05)。对照组不良反应发生率9.30%略低于观察组13.04%,但差异无统计学意义(P>0.05)。结论以胃乐新与兰索拉唑联合治疗消化性胃溃疡效果显著,能有效减轻患者溃疡症状,且不良反应发生率低,安全性高。 Objective To analyze the effect of Weilexin combined with Lansoprazole enteric-coated capsules in the treatment of peptic ulcer. Methods 89 patients with peptic ulcer were randomly divided into control group (43 cases) and observation group (46 cases). The control group given Weilexin treatment, the observation group in the control group plus lansoprazole treatment. Compare the treatment effect of two groups. Results There was no significant difference in abdominal pain, abdominal pain, acid reflux, nausea, vomiting and diarrhea between the two groups before treatment (P> 0.05). After treatment, the scores of each symptom in both groups were significantly lower than those before treatment, and the observation group was lower than Control group, the difference was statistically significant (P <0.05). The incidence of adverse reactions in the control group was 9.30% slightly lower than that in the observation group (13.04%), but the difference was not statistically significant (P> 0.05). Conclusion Weilexin combined with lansoprazole treatment of peptic ulcer significantly, can effectively reduce the symptoms of patients with ulcer, and the incidence of adverse reactions, high safety.